Stuart Poulton - EVP, Chief Development Officer at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Development Officer
Stock Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Stuart Poulton - trading volume in the past year for Karyopharm Therapeutics Inc.

Holdings reported by Stuart Poulton for Karyopharm Therapeutics Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 351,977 $466 K $1.32 Feb 28, 2024 Direct
Common 329,511 $395 K $1.20 Mar 1, 2024 Direct

Transactions reported by Stuart Poulton for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership